EYPT
EyePoint, Inc.
EyePoint, Inc. (EYPT) has 8 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 14, 2026.
The most active filer is Chief Medical Officer Ribeiro Ramiro with 3 filings. Insiders have net sold $134K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jay S. Duker
- Employees:214
- HQ:Watertown, MA, US
- IPO:2005-01-27
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$153K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$978.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 4,875 | $73K | Jul 2 | SEC ↗ | |
| Chief Medical Officer | Sale | 2,437 | $37K | Apr 20 | SEC ↗ | |
Duker Jay S.First filing | President and CEO | Purchase | 1,500 | $20K | Mar 16 | SEC ↗ |
Ribeiro RamiroFirst filing | Chief Medical Officer | Sale | 2,438 | $44K | Mar 5 | SEC ↗ |
Related companies
EyePoint, Inc. is in the Healthcare sector.